s6y

OMEROS CORP

Ticker
OMER
CIK
1285819
Industry
Pharmaceutical Preparations

Financials 71

  1. 10-Q Quarterly Report for period ending Sep 30, 2026
  2. 10-Q Quarterly Report for period ending Jun 30, 2026
  3. 10-Q Quarterly Report for period ending Mar 31, 2026
  4. 10-K Annual Report for period ending Dec 31, 2025
  5. 10-Q Quarterly Report for period ending Sep 30, 2025
  6. 10-Q Quarterly Report for period ending Jun 30, 2025
  7. 10-Q Quarterly Report for period ending Mar 31, 2025
  8. 10-K/A Annual Report for period ending Dec 31, 2024
  9. 10-K Annual Report for period ending Dec 31, 2024
  10. 10-Q Quarterly Report for period ending Sep 30, 2024

All 71 financials filings

News 183

  1. 8-K Current report filing
  2. 8-K Current report filing
  3. 8-K Current report filing
  4. 8-K Current report filing
  5. 8-K Current report filing
  6. 8-K Current report filing
  7. 8-K Current report filing
  8. 8-K Current report filing
  9. 8-K Current report filing
  10. 8-K Current report filing

All 183 news filings

Ownership 358

  1. 4 Statement of changes in beneficial ownership of securities
  2. 4 Statement of changes in beneficial ownership of securities
  3. 4 Statement of changes in beneficial ownership of securities
  4. 4 Statement of changes in beneficial ownership of securities
  5. 4 Statement of changes in beneficial ownership of securities
  6. 4 Statement of changes in beneficial ownership of securities
  7. 4 Statement of changes in beneficial ownership of securities
  8. 3 Initial statement of beneficial ownership of securities
  9. 4 Statement of changes in beneficial ownership of securities
  10. 4 Statement of changes in beneficial ownership of securities

All 358 ownership filings

Prospectus 71

  1. S-8 Initial registration statement for securities to be offered to employees pursuant to employee benefit plans
  2. 424B5 Prospectus filed pursuant to Rule 424(b)(5)
  3. S-3ASR Automatic shelf registration statement of securities of well-known seasoned issuers
  4. 424B5 Prospectus filed pursuant to Rule 424(b)(5)
  5. S-8 Initial registration statement for securities to be offered to employees pursuant to employee benefit plans
  6. 424B5 Prospectus filed pursuant to Rule 424(b)(5)
  7. 424B3 Prospectus filed pursuant to Rule 424(b)(3)
  8. S-3 Registration statement for specified transactions by certain issuers
  9. S-8 Initial registration statement for securities to be offered to employees pursuant to employee benefit plans
  10. 424B5 Prospectus filed pursuant to Rule 424(b)(5)

All 71 prospectus filings

Proxies 18

  1. DEF 14A Definitive proxy statements
  2. DEF 14A Definitive proxy statements
  3. DEF 14A Definitive proxy statements
  4. DEF 14A Definitive proxy statements
  5. DEF 14A Definitive proxy statements
  6. DEF 14A Definitive proxy statements
  7. DEFA14A Definitive additional proxy soliciting materials including Rule 14(a)(12) material. Note: Submission type DEFA14A can be filed as part of Form 8-K. For filers subject to 8-K filing requirements, we recommend the use of the 8-K combined form type as the easiest method for fulfilling your filing requirement for both forms.
  8. DEF 14A Definitive proxy statements
  9. DEF 14A Definitive proxy statements
  10. DEF 14A Definitive proxy statements

All 18 proxies filings

Other 111

  1. 144 Filing for proposed sale of securities under Rule 144
  2. 144 Filing for proposed sale of securities under Rule 144
  3. 144 Filing for proposed sale of securities under Rule 144
  4. 144 Filing for proposed sale of securities under Rule 144
  5. 144 Filing for proposed sale of securities under Rule 144
  6. 144 Filing for proposed sale of securities under Rule 144
  7. 144 Filing for proposed sale of securities under Rule 144
  8. 144 Filing for proposed sale of securities under Rule 144
  9. 144 Filing for proposed sale of securities under Rule 144
  10. SCHEDULE 13G/A

All 111 other filings